Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis (West Japan Oncolgy Group 6711L): A Phase II Study

SESSION TITLE: Diffuse Lung Disease Poster Discussions SESSION TYPE: Original Investigation Poster Discussion PRESENTED ON: Wednesday, October 28, 2015 at 02:45 PM - 04:00 PM PURPOSE: Idiopathic pulmonary fibrosis (IPF) is often accompanied by lung cancer, and acute exacerbation (AE) and AE-related mortality are experienced in 10-20% of IPF patinets who underwent surgery for lung cancer. Pirfenidone is an anti-fibrotic agent and proved to reduce...